Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NeoPharm files application for Phase II prostate cancer study
Laurence Birch, president and CEO of NeoPharm, said: “The preliminary results from our Phase I trial, which has not yet concluded, have been encouraging. As a result, we
Laurence Birch, president and CEO of NeoPharm, said: “The preliminary results from our Phase I trial, which has not yet concluded, have been encouraging. As a result, we
Dr Caspari’s initial primary responsibilities will include managing the development, FDA clinical trial and submission activities for AppyScore, the company’s diagnostic test for human appendicitis. Most recently, Dr
The Sleuth products offer physicians the ability to diagnose patients with recurrent, unexplained fainting and abnormal heart rhythms quickly with its virtually unlimited memory capacity and hands-free downloading
In addition, Mr Grossman will also be assuming the role of co-CEO, with no remuneration, to assist in XTL’s analysis of its strategic alternatives. Mr Grossman served as
The clinical study will assess the performance of OralAdvance compared to the gold standard biopsy and histology for its ability to differentiate between visually suspicious oral lesions with
Jeffrey Buchalter, chairman and CEO of Enzon, said: “As we previously demonstrated, Enzon maintains high standards for developing its important and novel compounds. While it did not achieve
Mr Blanchard brings more than 20 years of leadership experience in the global life sciences market to his new role, including senior level positions in corporate development, operations
Taro’s levetiracetam oral solution is a prescription medication used as an adjunctive therapy in the treatment of partial onset seizures in individuals with epilepsy. This new Taro product
Singapore-based Invida Pharmaceutical Holdings will market Sancuso in Australia, Indonesia, the Philippines, Thailand and Vietnam, while Dubai-based NewBridge Pharmaceuticals will market Sancuso in Turkey. ProStrakan has already partnered
Widely published in scientific journals and with over 100 invited presentations, Caniggia also serves as a reviewer for a number of leading peer-reviewed scientific journals and has been